Breast cancer in the male: A report of 138 cases

This is a report of 138 male patients with cancer of the breast who were treated at the Hellenic Anticancer Institute from 1937 to 1974. The overall 5-year survival rate for 120 patients followed up was 32.5%. Analysis of the 5-year survival rate in relation to the mode of treatment showed that for radical mastectomy it was 42.9%, for simple mastectomy 40.7%, and for lumpectomy 35%. There were no 5-year survivors among patients treated with a combination of radiotherapy, chemotherapy, and hormonal manipulation. The 5-year survival rate for stage I cancer was 54.6%, for stage II the rate was 48.7%, and for stage III it was 18.5%. There were no 5-year survivors with stage IV cancer. The 5-year survival rate for patients who underwent radical mastectomy with positive axillary lymph nodes was 30.8%, while for those in whom the axillary lymph nodes were negative it was 56.5%. The overall 10-year survival rate was 14.8%. Au Hellenic Anticancer Institute, 138 hommes atteints de cancer du sein ont été traités entre 1937 et 1974. La survie globale à 5 ans, pour 120 malades suivis, est de 32.5%. Elle est de 42.9% après mastectomie radicale, de 40.7% après mastectomie simple, de 35% après exérèse limitée à la tumeur. Il n'y a aucun survivant à 5 ans pour les malades traités par association de radio-, chimio- et hormonothérapie. La survie à 5 ans est de 54.6% pour les cancers au stade I, 48.7% pour les stades II, 18.5% pour les stades III et 0% pour les stades IV. Elle est de 30.8% pour les mastectomies radicales avec ganglions axillaires envahis et de 56.5% lorsque ces ganglions ne sont pas atteints. La survie globale à 10 ans est de 14.8%.